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Conventional X-ray radiography has been, and still is, 
the basic imaging technique for the diagnosis and mon-
itoring of rheumatic diseases. Recent years have seen 
a new addition to the arsenal of diagnostic methods 
available for these diseases: magnetic resonance imag-
ing (MRI). MRI is a noninvasive medical test which pro-
vides insights into tissue pathology that are impossible 
to obtain by X-ray analysis.
X-ray imaging in rheumatoid arthritis (RA) is based 
on the detection of cortical bone erosions, and in spon-
dyloarthropathies (SpAs) – erosions and sclerotization in 
the sacroiliac joints and syndesmophytes within the ver-
tebral bodies. An erosion located in the cortical bone is 
often a sine qua non precondition for RA diagnosis and, 
from the viewpoint of a rheumatologist and radiologist, 
the subchondral and trabecular bones are not so impor-
tant. Analogously, important X-ray findings in spondy-
loarthropathies are lesions on the “surface” of bones in 
the sacroiliac joints and vertebrae.
Over the past decade, the views have changed be-
cause of MRI application, and rheumatologists have 
taken an interest in the trabecular bone in joints and 
vertebral bodies. A direct impulse was the fact that 
MRI makes it possible to identify bone marrow oedema 
(BME), i.e. a concentrated inflammatory reaction in the 
trabecular bone which is undetectable by X-ray. From the 
histological point of view, it is an area of the so-called 
osteitis containing activated osteoclasts, T- and B-cells, 
macrophages and plasma cells.
Relationships existing between BME and changes in 
the synovial membrane, cortical bone and attachments 
are the field of study of osteoimmunology. It is progress 
in this discipline that has enhanced the status of MRI 
in the imaging of inflammatory rheumatic diseases, and 
particularly in BME detection. In this sense, MRI can be 
seen as a specific type of bone biopsy.
In addition to providing “on-off” information about 
a progressing inflammation, BME also has a prognostic 
value. In RA, BME is a biomarker of the erosive form of 
the disease. BME detection in early RA is related to an 
unfavourable course of the disease – not only within the 
bone affected by erosions [1], but also the cartilage and 
tendons invaded by pannus – and correlates with de-
teriorated physical function. In spondyloarthropathies, 
BME detection within the sacroiliac joints points to the 
diagnosis of the so-called non-radiographic axial spon-
dyloarthropathy (nr-axSpA) which, according to new 
classification criteria, is one of two forms of axial SpA 
(axSpA) apart from ankylosing spondylitis (AS). BME can 
bring forward by a couple of years the diagnosis of in-
flammation, and in fact already structural damage seen 
on radiograms. In the vertebrae, syndesmophytes most 
typically form in sites of previously diagnosed BME.
Following publications addressing the use of MRI in 
rheumatology, the European League Against Rheuma-
tism (EULAR) developed recommendations for the appli-
cation of imaging methods, MRI included, which were 
published in the Annals of the Rheumatic Diseases – for 
RA in 2013 [2], and for SpA in 2015 [3]. 
Although from the viewpoint of pathophysiology of 
rheumatic inflammatory diseases and osteoimmunolo-
gy – which monitor interactions between the immune 
system and bone tissue – BME is per se a symptom of 
inflammation, translating that symptom into clinical 
practice came up against a range of difficulties. First of 
all, evidence pointing to a range of falsely positive MRI 
results was published. For example, erosions in RA can 
be canals of blood vessels feeding the bones or tendon 
and ligament attachments. Similarly, syndesmophytes 
did not form in all BME sites in vertebral bodies, and the 
presence of BME in MRI failed to translate into further 
“growth” of already formed syndesmophytes [4]. Finally, 
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a study was published which questioned the presence 
of BME in vertebral bodies as a symptom sufficient for 
diagnosing nr-axSpA [5]. BME-like lesions in the sacroil-
iac joints have also been found in healthy people pursu-
ing endurance sports (e.g. long-distance running) on an 
amateur level.
It is also worthwhile to note that in SpA treatment 
the presence of BME is a predictor of good response to 
TNF inhibitor therapy – both in AS and nr-axSpA (ABILITY, 
RAPID-axSpA, ESTHER, GO-RAISE and GO-AHEAD trials). 
The studied TNF inhibitors suppress inflammatory le-
sions, primarily BME, in the sacroiliac joints and verte-
bral bodies. The application of these drugs in nr-axSpA 
gives rise to the question about the window of oppor-
tunity, i.e. whether early inhibition of the inflammation 
affects the natural course of axial SpA, perhaps inhibit-
ing osteogenesis and preventing the patient from devel-
oping AS.  
The cooperation between rheumatologists and ra-
diologists in MRI, however, leaves a lot to be desired. 
Despite a few rare exceptions to the contrary, radiology 
centres lack MRI specialists in inflammatory diseases of 
the musculoskeletal system, and interpretations of MRI 
scans fail to come up to the expectations of the referring 
rheumatologist. On the other hand, rheumatologists 
have a limited knowledge and experience in interpret-
ing MRI scans and integrating them with practice. Po-
land does not have any radiology centre that would train 
rheumatologists in this area. Therefore, the attempt un-
dertaken by a group of radiologists and rheumatologists 
to develop a consensus on MRI in RA and SpA which was 
published in this issue of Reumatologia, and before that 
in a leading radiology journal [6], systematizes common 
efforts towards making a better use of MRI in rheumatol-
ogy. The first move has already been made. The second 
will be a session devoted to MRI in RA and SpA during 
this year’s 5th National Rheumatology Meetings in Lub-
lin. Owing to the favourable attitude of the organizers, 
the session will be included in the plenary agenda. In 
addition to that session, the imaging diagnostics section 
of the Polish Society of Rheumatology will hold a less 
formal meeting for discussing the proposed recommen-
dations – including a universal template for a referral 
to a MRI scan in RA and SpA cases. What will be the 
expectations of rheumatological and radiological circles 
on this matter? Perhaps the next step will involve the 
organization of courses for rheumatologists and radiol-
ogists conducted by a team of experts in both medical 
fields? The time will show.
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